ACE and heart failure: ASCO guidelines for monitoring and preventing cardiac dysfunction after doxorubicin therapy state that currently there is not sufficient evidence to recommend any single heart failure medication such as angiotensin-converting enzyme (ACE) inhibitors or beta blockers to improve function (15).